Zebra Medical Vision’s AI Reads Medical Images. Now Comes the Hospital Test
Nanox.AI, formerly Zebra Medical Vision, is now the imaging software unit of Nasdaq-listed Nanox, which acquired Zebra for $100 million in 2021. The company reported losses and financing risk in its 2026 filing but said it added Cedars-Sinai as a trial partner and accelerated U.S. deployment of its Nanox.ARC systems. NICE approved Nanox AI tools for NHS use during a three-year evidence period. FDA cleared its HealthFLD liver analysis software in 2024.